Observational studyBMC pharmacology & toxicology2019

Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center.

Milana Bergamino Sirvén et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.